The TYLAXEN brand, founded in 2012 (France), from 203 sister brands and 17477 competing brands. TYLAXEN is owned by VIRBAC, listed on the stock exchange of Paris The International Securities Identification Number (ISIN) of VIRBAC is FR0000031577. TYLAXEN is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
VIRBAC
(TYLAXEN)
over 5 years*
EUR 756.76